Our findings are also in concordance with recent studies that demonstrated HDAC and Bet-Bromodomain inhibitors to regulate common transcriptional networks in Myc-induced murine lymphoma cells (Bhadury et al., 2014). The gene discussed is MYC; the disease is lymphoma.